HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

Is Immunotherapy Effective At Treating Lung And Brain Lesions-melanomas?

default
Posted on Fri, 12 Oct 2018
Question: a relative has 3 lung lesions and 3 brain lesions - melanomas. is immunotherapy a possible treatment?
doctor
Answered by Dr. Ishu Bishnoi (21 minutes later)
Brief Answer:

Immunotherapy an adjuvant therapy

Detailed Answer:

Hi,

Your relative is suffering from metastatic melanoma. Along with other therapies, immunotherapy is used as adjuvant therapy.

Development of checkpoint inhibitors directed against CTLA-4 and PD-1 have demonstrated impressive clinical outcomes in the treatment of metastatic melanoma.

Studies are continuing to evaluate combination immunotherapy regimens including nivolumab and ipilimumab, IFN-α and ipilimumab, and multiple anti-PD1/PDL1-based combination studies. Studies of other immune checkpoint modulators including CD40, OX40, and CD137 among others are also ongoing.

It has been proved by various studies. If you want, you can read an article about it -The use of immunotherapy in the treatment of melanoma. XXXXXXX Achkar and; XXXXXXX A. TarhiniEmail author. Journal of Hematology & Oncology201710:88.

Hope I have answered your query.

Take care

Regards,
Dr Ishu Bishnoi, Neurologist, Surgical
Above answer was peer-reviewed by : Dr. Prasad
doctor
Answered by
Dr.
Dr. Ishu Bishnoi

Neurologist, Surgical

Practicing since :2007

Answered : 901 Questions

Ask a specialist now
premium_optimized

The User accepted the expert's answer

Ask a Neurologist
Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
backtotop2
Is Immunotherapy Effective At Treating Lung And Brain Lesions-melanomas?

Brief Answer: Immunotherapy an adjuvant therapy Detailed Answer: Hi, Your relative is suffering from metastatic melanoma. Along with other therapies, immunotherapy is used as adjuvant therapy. Development of checkpoint inhibitors directed against CTLA-4 and PD-1 have demonstrated impressive clinical outcomes in the treatment of metastatic melanoma. Studies are continuing to evaluate combination immunotherapy regimens including nivolumab and ipilimumab, IFN-α and ipilimumab, and multiple anti-PD1/PDL1-based combination studies. Studies of other immune checkpoint modulators including CD40, OX40, and CD137 among others are also ongoing. It has been proved by various studies. If you want, you can read an article about it -The use of immunotherapy in the treatment of melanoma. XXXXXXX Achkar and; XXXXXXX A. TarhiniEmail author. Journal of Hematology & Oncology201710:88. Hope I have answered your query. Take care Regards, Dr Ishu Bishnoi, Neurologist, Surgical